Literature DB >> 21310434

Involvement of pontine transverse and longitudinal fibers in multiple system atrophy: a tractography-based study.

Takahiro Makino1, Shoichi Ito, Satoshi Kuwabara.   

Abstract

OBJECTIVE: Pathological studies showed both pontine transverse (cortico-ponto-cerebellar) and longitudinal (corticospinal) fibers degenerate in MSA. The objective was to investigate the association between the development of cross sign, degenerations of pontine fibers, and the frequency of pyramidal signs in MSA.
METHODS: Patients with MSA (n=26) and healthy subjects (n=27) were enrolled in this study. Whole pontine transverse and longitudinal fibers were individually traced by diffusion tensor tractography. FA was calculated along each entire tractography. Cross sign was graded as: 0, no cross sign; 1, anterior-posterior line only; and 2, complete cross sign. T2-hyperintense MCPs was graded as: 0, no change; 1, slight signal change; and 2, severe signal change. FA of pontine fibers in MSA patients and that in healthy subjects was statistically evaluated by ANOVA with an overall statistical significance level of 0.05. The frequency of pyramidal signs in MSA was compared between each cross and MCP grade.
RESULTS: FA of pontine transverse fibers in MSA patients decreased with the development of cross sign. FA of Cross 2 was significantly lower than that of healthy subjects (p=0.003). As regards pontine longitudinal fibers, FA decreased when cross sign was completed. The frequency of pyramidal signs in MCP 2 and 1 was higher than that in MCP 0.
CONCLUSION: Pontine transverse fibers degenerate as cross sign develop, and degenerations of pontine longitudinal fibers begin, or even accelerate when cross sign becomes apparent. Pyramidal signs are frequently present when T2-hyperintense MCPs are clearly observed.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21310434     DOI: 10.1016/j.jns.2011.01.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.

Authors:  Claire J Cochrane; Klaus P Ebmeier
Journal:  Neurology       Date:  2013-02-26       Impact factor: 9.910

2.  3T MRI Whole-Brain Microscopy Discrimination of Subcortical Anatomy, Part 1: Brain Stem.

Authors:  M J Hoch; M T Bruno; A Faustin; N Cruz; L Crandall; T Wisniewski; O Devinsky; T M Shepherd
Journal:  AJNR Am J Neuroradiol       Date:  2019-01-31       Impact factor: 3.825

3.  High-resolution anatomy of the human brain stem using 7-T MRI: improved detection of inner structures and nerves?

Authors:  Elke R Gizewski; Stefan Maderwald; Jennifer Linn; Benjamin Dassinger; Katja Bochmann; Michael Forsting; Mark E Ladd
Journal:  Neuroradiology       Date:  2013-12-20       Impact factor: 2.804

4.  New Clinically Feasible 3T MRI Protocol to Discriminate Internal Brain Stem Anatomy.

Authors:  M J Hoch; S Chung; N Ben-Eliezer; M T Bruno; G M Fatterpekar; T M Shepherd
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-11       Impact factor: 3.825

5.  Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.

Authors:  J Brettschneider; D J Irwin; S Boluda; M D Byrne; L Fang; E B Lee; J L Robinson; E Suh; V M Van Deerlin; J B Toledo; M Grossman; H Hurtig; R Dengler; S Petri; V M-Y Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2016-10-18       Impact factor: 8.090

Review 6.  Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy.

Authors:  Han-Joon Kim; Beomseok Jeon; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2016-07-28

7.  Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography.

Authors:  Yulia Surova; Filip Szczepankiewicz; Jimmy Lätt; Markus Nilsson; Bengt Eriksson; Alexander Leemans; Oskar Hansson; Danielle van Westen; Christer Nilsson
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.